Platelet-derived growth factor receptor α/glial fibrillary acidic protein expressing peritumoral astrocytes associate with shorter median overall survival in glioblastoma patients.


Journal

Glia
ISSN: 1098-1136
Titre abrégé: Glia
Pays: United States
ID NLM: 8806785

Informations de publication

Date de publication:
05 2020
Historique:
received: 21 05 2019
revised: 07 11 2019
accepted: 11 11 2019
pubmed: 27 11 2019
medline: 11 6 2021
entrez: 27 11 2019
Statut: ppublish

Résumé

The microenvironment and architecture of peritumoral tissue have been suggested to affect permissiveness for infiltration of malignant cells. Astrocytes constitute a heterogeneous population of cells and have been linked to proliferation, migration, and drug sensitivity of glioblastoma (GBM) cells. Through double-immunohistochemical staining for platelet-derived growth factor receptor α (PDGFRα) and glial fibrillary acidic protein (GFAP), this study explored the intercase variability among 45 human GBM samples regarding density of GFAP+ peritumoral astrocytes and a subset of GFAP+ peritumoral astrocyte-like cells also expressing PDGFRα. Large intercase variability regarding the total peritumoral astrocyte density and the density of PDGFRα+/GFAP+ peritumoral astrocyte-like cells was detected. DNA fluorescence in situ hybridization analyses for commonly altered genetic tumor markers supported the interpretation that these cells represented a genetically unaffected host cell subset referred to as PDGFRα+/GFAP+ peritumoral astrocytes. The presence of PDGFRα+/GFAP+ peritumoral astrocytes was significantly positively correlated to older patient age and peritumoral astrocyte density, but not to other established prognostic factors. Notably, presence of PDGFRα+/GFAP+ peritumoral astrocytes, but not peritumoral astrocyte density, was associated with significantly shorter patient overall survival. The prognostic association of PDGFRα+/GFAP+ peritumoral astrocytes was confirmed in multivariable analyses. This exploratory study thus demonstrates previously unrecognized intercase variability and prognostic significance of peritumoral abundance of a novel PDGFRα+ subset of GFAP+ astrocytes. Findings suggest clinically relevant roles of the microenvironment of peritumoral GBM tissue and encourage further characterization of the novel astrocyte subset with regard to origin, function, and potential as biomarker and drug target.

Identifiants

pubmed: 31769546
doi: 10.1002/glia.23756
doi:

Substances chimiques

Biomarkers, Tumor 0
Glial Fibrillary Acidic Protein 0
Receptors, Platelet-Derived Growth Factor EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

979-988

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Références

Adamo, H., Hammarsten, P., Hagglof, C., Dahl Scherdin, T., Egevad, L., Stattin, P., … Bergh, A. (2019). Prostate cancer induces C/EBPbeta expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome. Prostate, 79(5), 435-445. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30536410. https://doi.org/10.1002/pros.23749
Bachoo, R. M., Kim, R. S., Ligon, K. L., Maher, E. A., Brennan, C., Billings, N., … DePinho, R. A. (2004). Molecular diversity of astrocytes with implications for neurological disorders. Proceedings of the National Academy of Sciences of the United States of America, 101(22), 8384-8389. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15155908. https://doi.org/10.1073/pnas.0402140101
Brandao, M., Simon, T., Critchley, G., & Giamas, G. (2019). Astrocytes, the rising stars of the glioblastoma microenvironment. Glia, 67(5), 779-790. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30240060. https://doi.org/10.1002/glia.23520
Dai, C., Celestino, J. C., Okada, Y., Louis, D. N., Fuller, G. N., & Holland, E. C. (2001). PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes & Development, 15(15), 1913-1925. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11485986. https://doi.org/10.1101/gad.903001
Darnell, J. E., Jr. (1997). STATs and gene regulation. Science, 277(5332), 1630-1635 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9287210.
Gril, B., Palmieri, D., Qian, Y., Anwar, T., Liewehr, D. J., Steinberg, S. M., … Vidal-Vanaclocha, F. (2013). Pazopanib inhibits the activation of PDGFRbeta-expressing astrocytes in the brain metastatic microenvironment of breast cancer cells. The American Journal of Pathology, 182(6), 2368-2379. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23583652. https://doi.org/10.1016/j.ajpath.2013.02.043
Hermanson, M., Funa, K., Hartman, M., Claesson-Welsh, L., Heldin, C. H., Westermark, B., & Nister, M. (1992). Platelet-derived growth factor and its receptors in human glioma tissue: Expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Research, 52(11), 3213-3219. Retrieved from Human Protein Atlas. Retrieved from https://www.proteinatlas.org/ https://www.ncbi.nlm.nih.gov/pubmed/1317261.
Jackson, E. L., Garcia-Verdugo, J. M., Gil-Perotin, S., Roy, M., Quinones-Hinojosa, A., VandenBerg, S., & Alvarez-Buylla, A. (2006). PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron, 51(2), 187-199. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/16846854. https://doi.org/10.1016/j.neuron.2006.06.012
John Lin, C. C., Yu, K., Hatcher, A., Huang, T. W., Lee, H. K., Carlson, J., … Deneen, B. (2017). Identification of diverse astrocyte populations and their malignant analogs. Nature Neuroscience, 20(3), 396-405. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28166219. https://doi.org/10.1038/nn.4493
Katz, A. M., Amankulor, N. M., Pitter, K., Helmy, K., Squatrito, M., & Holland, E. C. (2012). Astrocyte-specific expression patterns associated with the PDGF-induced glioma microenvironment. PLoS One, 7(2), e32453. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/22393407. https://doi.org/10.1371/journal.pone.0032453
Kim, J. K., Jin, X., Sohn, Y. W., Jin, X., Jeon, H. Y., Kim, E. J., … Kim, H. (2014). Tumoral RANKL activates astrocytes that promote glioma cell invasion through cytokine signaling. Cancer Letters, 353(2), 194-200. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25079688. https://doi.org/10.1016/j.canlet.2014.07.034
Lin, J. H., Takano, T., Cotrina, M. L., Arcuino, G., Kang, J., Liu, S., … Nedergaard, M. (2002). Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. The Journal of Neuroscience, 22(11), 4302-4311 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12040035
Montana, V., & Sontheimer, H. (2011). Bradykinin promotes the chemotactic invasion of primary brain tumors. The Journal of Neuroscience, 31(13), 4858-4867. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21451024. https://doi.org/10.1523/JNEUROSCI.3825-10.2011
Mudhar, H. S., Pollock, R. A., Wang, C., Stiles, C. D., & Richardson, W. D. (1993). PDGF and its receptors in the developing rodent retina and optic nerve. Development, 118(2), 539-552 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8223278
Paulsson, J., Lindh, M. B., Jarvius, M., Puputti, M., Nister, M., Nupponen, N. N., … Hasselblatt, M. (2011). Prognostic but not predictive role of platelet-derived growth factor receptors in patients with recurrent glioblastoma. International Journal of Cancer, 128(8), 1981-1988. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/20589679. https://doi.org/10.1002/ijc.25528
Placone, A. L., Quinones-Hinojosa, A., & Searson, P. C. (2016). The role of astrocytes in the progression of brain cancer: Complicating the picture of the tumor microenvironment. Tumour Biology, 37(1), 61-69. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26493995. https://doi.org/10.1007/s13277-015-4242-0
Priego, N., Zhu, L., Monteiro, C., Mulders, M., Wasilewski, D., Bindeman, W., … Valiente, M. (2018). STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis. Nature Medicine, 24(7), 1024-1035. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/29892069. https://doi.org/10.1038/s41591-018-0044-4
Scherer, H. J. (1938). Structural development of gliomas. The American Journal of Cancer, XXXIV(3), 333-351.
Schiweck, J., Eickholt, B. J., & Murk, K. (2018). Important Shapeshifter: Mechanisms allowing astrocytes to respond to the changing nervous system during development, injury and disease. Frontiers in Cellular Neuroscience, 12, 261. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30186118. https://doi.org/10.3389/fncel.2018.00261
Sherriff, J., Tamangani, J., Senthil, L., Cruickshank, G., Spooner, D., Jones, B., … Sanghera, P. (2013). Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide. The British Journal of Radiology, 86(1022), 20120414. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23385995. https://doi.org/10.1259/bjr.20120414
Strell, C., Paulsson, J., Jin, S. B., Tobin, N. P., Mezheyeuski, A., Roswall, P., … Ostman, A. (2019). Impact of epithelial-stromal interactions on peritumoral fibroblasts in ductal carcinoma in situ. Journal of the National Cancer Institute, 111(9), 983-995. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30816935. https://doi.org/10.1093/jnci/djy234
Troester, M. A., Lee, M. H., Carter, M., Fan, C., Cowan, D. W., Perez, E. R., … Schneider, S. S. (2009). Activation of host wound responses in breast cancer microenvironment. Clinical Cancer Research, 15(22), 7020-7028. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19887484. https://doi.org/10.1158/1078-0432.CCR-09-1126
Zagzag, D., Esencay, M., Mendez, O., Yee, H., Smirnova, I., Huang, Y., … Newcomb, E. W. (2008). Hypoxia- and vascular endothelial growth factor-induced stromal cell-derived factor-1alpha/CXCR4 expression in glioblastomas: One plausible explanation of Scherer's structures. The American Journal of Pathology, 173(2), 545-560. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/18599607. https://doi.org/10.2353/ajpath.2008.071197
Zeisel, A., Hochgerner, H., Lonnerberg, P., Johnsson, A., Memic, F., van der Zwan, J., … Linnarsson, S. (2018). Molecular architecture of the mouse nervous system. Cell, 174(4), 999-1014 e1022. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30096314. https://doi.org/10.1016/j.cell.2018.06.021

Auteurs

Lina Leiss (L)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Alessandro Mega (A)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Thomas Olsson Bontell (T)

Department of Clinical Pathology and Cytology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Acandemy, University of Gothenburg, Sweden.

Monica Nistér (M)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Anja Smits (A)

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden.
Department of Neuroscience, Neurology, Uppsala University, Uppsala, Sweden.

Sara Corvigno (S)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Mohummad Aminur Rahman (MA)

Department of Biomedicine, University of Bergen, Bergen, Norway.

Per Øyvind Enger (PØ)

Department of Biomedicine, University of Bergen, Bergen, Norway.
Department of Neurosurgery, Haukeland University Hospital, Bergen, Norway.

Hrvoje Miletic (H)

Department of Biomedicine, University of Bergen, Bergen, Norway.
Department of Pathology, Haukeland University Hospital, Bergen, Norway.

Arne Östman (A)

Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH